Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Urinary Bladder, Overactive × Genitourinary × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 499 Urinary Bladder Neoplasms 138 Carcinoma, Renal Cell 116 Neoplasms 65 Kidney Neoplasms 53 Non-Muscle Invasive Bladder Neoplasms 42 Neoplasm Metastasis 38 Carcinoma, Transitional Cell 37 Breast Neoplasms 30 Testicular Neoplasms 28 Recurrence 20 Wilms Tumor 18 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Pain 13 Ovarian Neoplasms 13 Testicular Germ Cell Tumor 12 Teratoma 12 Seminoma 12 Multiple Myeloma 12 Burkitt Lymphoma 12 Urologic Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 11 Carcinoma, Ovarian Epithelial 11 Carcinoma 11 Neuroblastoma 10 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large-Cell, Immunoblastic 10 Lymphoma, Follicular 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02805452 2018-01-19

VesiCaP

Center Eugene Marquis

Phase 3 Terminated

Urinary Bladder, Overactive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡